Related Experiment Video
Updated: Feb 1, 2026

Ex vivo Live Imaging of Lung Metastasis and Their Microenvironment
Published on: February 3, 2016
The lung microenvironment: an important regulator of tumour growth and metastasis
Nasser K Altorki1,2,3, Geoffrey J Markowitz1,2, Dingcheng Gao1,2,3,4
1Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York, NY, USA.
Abstract:
Lung cancer is a major global health problem, as it is the leading cause of cancer-related deaths worldwide. Major advances in the identification of key mutational alterations have led to the development of molecularly targeted therapies, whose efficacy has been limited by emergence of resistance mechanisms. US Food and Drug Administration (FDA)-approved therapies targeting angiogenesis and more recently immune checkpoints have reinvigorated enthusiasm in elucidating the prognostic and pathophysiological roles of the tumour microenvironment in lung cancer. In this Review, we highlight recent advances and emerging concepts for how the tumour-reprogrammed lung microenvironment promotes both primary lung tumours and lung metastasis from extrapulmonary neoplasms by contributing to inflammation, angiogenesis, immune modulation and response to therapies. We also discuss the potential of understanding tumour microenvironmental processes to identify biomarkers of clinical utility and to develop novel targeted therapies against lung cancer.
Insights
Lung cancer, a leading cause of cancer deaths, involves complex tumor microenvironments. Understanding these environments offers new strategies for targeted lung cancer therapies and biomarkers.
Area of Science:
- Oncology
- Cancer Biology
- Immunology
Background:
- Lung cancer is a leading global cause of cancer mortality.
- Molecularly targeted therapies show promise but face resistance.
- The tumor microenvironment's role in lung cancer is increasingly recognized.
Purpose of the Study:
- To review recent advances in understanding the lung tumor microenvironment.
- To explore how the microenvironment influences primary tumors and metastasis.
- To discuss therapeutic and biomarker potential.
Main Methods:
- Literature review of recent advances in lung cancer research.
- Synthesis of concepts on tumor microenvironment reprogramming.
- Analysis of inflammation, angiogenesis, and immune modulation.
Main Results:
- The reprogrammed lung microenvironment promotes primary tumor growth and metastasis.
- Key processes include inflammation, angiogenesis, and immune modulation.
- Emerging concepts highlight the microenvironment's impact on therapy response.
Conclusions:
- The lung tumor microenvironment is crucial for cancer progression and therapy resistance.
- Targeting microenvironmental processes may overcome resistance.
- Biomarkers and novel therapies can be developed from this understanding.
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
The Tumor Microenvironment
Lung Capacity
Epigenetic Regulation
GTPases and their Regulation
Large G-proteins,...
Hormonal Regulation

